DIABETES AND KIDNEY SCIENCE AND THERAPEUTICS
Integration of pharmacologic knowledge and clinical decision-making to optimize patient management of diabetes and kidney-related health conditions. Emphasis on patient assessment and provision of evidence-based practices through application of pharmacotherapy principles, and drug monitoring to support person-centered care.
Prerequisites & course information
Requisites: PHARMACY 535 and 536 Course Designation: Grad 50% - Counts toward 50% graduate coursework requirement Repeatable for Credit: No Learning Outcomes: 1. Assess diabetes and kidney-related health conditions by evaluating diagnostic criteria, risk factors, etiology, and treatment goals. Audience: Graduate 2. Differentiate among the therapeutic drug classes used for diabetes and kidney-related health conditions based on mechanisms of action, clinical use, adverse effects, contraindications, interactions, and dosage forms used for diabetes and kidney-related health conditions. Audience: Graduate 3. Explain why a drug is selected for diabetes or kidney-related health conditions, or person based on its properties. Audience: Graduate 4. Design a person-centered care plan consisting of both drug and non-drug elements appropriate for an individual with diabetes and kidney-related health conditions using evidence-based principles and guidelines. Audience: Graduate 5. Evaluate a person-centered care plan to optimize safety and efficacy, considering patient-specific factors, to improve therapeutic outcomes for diabetes and kidney-related health conditions. Audience: Graduate Learning Outcomes: 1. Assess diabetes and kidney-related health conditions by evaluating diagnostic criteria, risk factors, etiology, and treatment goals. Audience: Graduate 2. Differentiate among the therapeutic drug classes used for diabetes and kidney-related health conditions based on mechanisms of action, clinical use, adverse effects, contraindications, interactions, and dosage forms used for diabetes and kidney-related health conditions. Audience: Graduate 3. Explain why a drug is selected for diabetes or kidney-related health conditions, or person based on its properties. Audience: Graduate 4. Design a person-centered care plan consisting of both drug and non-drug elements appropriate for an individual with diabetes and kidney-related health conditions using evidence-based principles and guidelines. Audience: Graduate 5. Evaluate a person-centered care plan to optimize safety and efficacy, considering patient-specific factors, to improve therapeutic outcomes for diabetes and kidney-related health conditions. Audience: Graduate
Sources
- Course catalogue ↗2026-2027